overcoming the challenges in prolonging remission in aml
Published 3 months ago • 85 plays • Length 0:56Download video MP4
Download video MP3
Similar videos
-
1:18
an insight into the challenges in prolonging remission in aml
-
1:35
an overview of the main challenges to prolonging remission in aml
-
2:19
maintaining remission in aml and improving long-term survival in patients who do not receive hsct
-
3:37
challenges and unmet needs in mpns: transplant decision-making and the management of mpn-ap/bp
-
2:15
extending remission in patients with aml who become eligible for allosct following targeted therapy
-
2:16
the challenges in producing efficacious i-o products for aml
-
6:16
the challenge of survivorship in aml
-
1:45
overcoming on-target, off-tumor toxicity in aml: current challenges and potential solutions
-
2:47
living with polycythemia vera? you’re not alone. wilma’s journey with pv
-
4:29
blood cancer is not a death sentence: types, treatment and life
-
34:52
phagocytic deficiencies (congenital neutropenia)
-
1:41
the challenges with implementing car-t into the aml treatment landscape
-
1:29
poor outcomes of patients with aml who relapse underscores the need for effective initial treatment
-
1:21
the remnant study: will treating patients at mrd relapse improve survival outcomes?
-
1:09
pre-measure: patients with aml in complete remission but high risk of relapse following allohct
-
2:20
overcoming lack of diversity in cancer clinical trials
-
1:22
unanswered questions in aml: classification, the role of chemotherapy & avoiding relapse
-
3:59
the challenges of post-mpn aml
-
0:48
an overview of challenges that remain in the treatment of patients with al amyloidosis
-
0:47
challenges in treating pv and optimal management strategies
-
3:30
clinical value of event-free survival in aml
-
2:18
treating patients with advanced-stage hl in the frontline and relapsed settings in 2024